Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1)
Open Access
- 6 August 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 31 (11), 2443-2456
- https://doi.org/10.1002/stem.1499
Abstract
Human mesenchymal stem/precursor cells (MSC) are similar to some other stem/progenitor cells in that they compact into spheres when cultured in hanging drops or on nonadherent surfaces. Assembly of MSC into spheres alters many of their properties, including enhanced secretion of factors that mediate inflammatory and immune responses. Here we demonstrated that MSC spontaneously aggregated into sphere-like structures after injection into a subcutaneous air pouch or the peritoneum of mice. The structures were similar to MSC spheres formed in cultures demonstrated by the increased expression of genes for inflammation-modulating factors TSG6, STC1, and COX2, a key enzyme in production of PGE2. To identify the signaling pathways involved, hanging drop cultures were used to follow the time-dependent changes in the cells as they compacted into spheres. Among the genes upregulated were genes for the stress-activated signaling pathway for IL1α/β, and the contact-dependent signaling pathway for Notch. An inhibitor of caspases reduced the upregulation of IL1A/B expression, and inhibitors of IL1 signaling decreased production of PGE2, TSG6, and STC1. Also, inhibition of IL1A/B expression and secretion of PGE2 negated the anti-inflammatory effects of MSC spheres on stimulated macrophages. Experiments with γ-secretase inhibitors suggested that Notch signaling was also required for production of PGE2 but not TSG6 or STC1. The results indicated that assembly of MSC into spheres triggers caspase-dependent IL1 signaling and the secretion of modulators of inflammation and immunity. Similar aggregation in vivo may account for some of the effects observed with administration of the cells in animal models. Stem Cells 2013;31:2443–2456Keywords
Funding Information
- NIH (P40RR17447)
- Cancer Prevention and Research Institute of Texas (RP110553-P1)
This publication has 40 references indexed in Scilit:
- Sending the right signal: Notch and stem cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Genetic visualization of notch signaling in mammalian neurogenesisCellular and Molecular Life Sciences, 2012
- Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular DiseaseCell Stem Cell, 2012
- Notch Inhibition as a Promising New Approach to Cancer TherapyAdvances in experimental medicine and biology, 2012
- Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of InflammationMolecular Therapy, 2012
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem CellsCell Stem Cell, 2011
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory propertiesProceedings of the National Academy of Sciences of the United States of America, 2010
- Cellular phenotype switching and microvesiclesAdvanced Drug Delivery Reviews, 2010
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009